Drug & intervention

pimecrolimus

RxCUI 321952

Clinical trials1
Recruiting0
Related conditions1
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Pimecrolimus

Pimecrolimus is an immunosuppressant drug of the calcineurin inhibitor class used in the treatment of atopic dermatitis (eczema). It is available as a topical cream. It was developed and formerly marketed by Novartis under the trade name Elidel.

Read on Wikipedia ↗ Wikidata Q417489 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.